Although only the PFS improvement of COPD in the EC + PD‐L1 group reached statistical significance, a positive trend was also observed in ORR.
← all excerpts
The Favorable Short-Term Efficacy of Preexisting COPD for Extensive-Stage Small-Cell Lung Cancer Receiving Immunotherapy.
1
—
—